Ray Dalio View Ray, Inc. Transaction History

Bridgewater Associates, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$3.28 - $4.81 $24,009 - $35,209	7,320 Added 3.64%	208,568 $721,000
Q4 2022 Feb 13, 2023	SELL	$3.65 - $4.82 $249,072 - $328,911	-68,239 Reduced 25.32%	201,248 $901,000
Q3 2022 Nov 10, 2022	BUY	$2.66 - $3.97 $1,407 - $2,100	529 Added 0.2%	269,487 $981,000
Q2 2022 Aug 11, 2022	BUY	$2.42 - $4.05 $57,666 - $96,507	23,829 Added 9.72%	268,958 $713,000
Q1 2022 May 13, 2022	BUY	$3.45 - $5.83 $209,573 - $354,149	60,746 Added 32.95%	245,129 $961,000
Q4 2021 Feb 14, 2022	BUY	$4.89 - $7.59 $197,815 - $307,038	40,453 Added 28.11%	184,383 $1.02 Million
Q3 2021 Nov 12, 2021	BUY	$5.18 - $7.41 $745,557 - $1.07 Million	143,930 New	143,930 $1.04 Million

645K

50K

30K

Ticker VRAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 181,010,000
Market Cap $1.81M
Description
ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin tox...

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.